Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
SWOG Cancer Research Network
OHSU Knight Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto